The FDA has recently required drug companies to provide warnings on the labels of all antidepressants because of evidence that these drugs may induce
a. suicidal ideation or behaviors in a small proportion of depressed patients at the beginning of their treatment
b. parkinsonian-like symptoms in elderly patients
c. hypertensive crises when combined with certain foods or other drugs
d. convulsions in certain patients
Question 2
Recent evidence suggests that monoamine oxidase inhibitors have the greatest efficacy in the treatment of
a. atypical depressions
b. schizophrenics
c. manic patients
d. bipolar depressives
Intramuscular drug administration: (a) cross section of skin showing depth of needle insertion
Effect of Perceived Price of a Drug on Placebo Analgesia
Types of pharmacokinetic drug–drug interactions.
Routes of Drug Administration: Advantages and Disadvantages
Clinically Significant Drug-Drug Interactions in Dentistry
An example of the key features of pesticide labels. The EPA requires the inclusion of specific ...